Trajenta 5 mg

Trajenta (linagliptin) is a medication used to treat type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing insulin production and decreasing glucose production in the liver. Trajenta is taken orally in tablet form, usually once daily, with or without food. It helps lower blood sugar levels and can be used alone or in combination with other antidiabetic medications. Common side effects may include upper respiratory tract infections and headache. It's important to follow the prescribed dosage and regularly monitor blood sugar levels while taking Trajenta. Consulting a healthcare provider for proper guidance and monitoring is essential for safe and effective use.